Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
Top Cited Papers
- 1 October 2002
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 1 (6), 383-386
- https://doi.org/10.1016/s1474-4422(02)00164-3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathwaysNature Neuroscience, 2002
- Selfotel in Acute Ischemic StrokeStroke, 2000
- Failure of the competitive N-methyl-d-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trialsJournal of Neurosurgery, 1999
- Acute Stroke Therapy at the Millennium: Consummating the Marriage Between the Laboratory and BedsideStroke, 1999
- bcl-2 is expressed in neurons that survive focal ischemia in the ratNeuroReport, 1995
- Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonistsNature, 1991
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984
- L-Glutamate has higher affinity than other amino acids for [3H]-D-AP5 binding sites in rat brain membranesNature, 1984
- Brain Lesions in an Infant Rhesus Monkey Treated with Monosodium GlutamateScience, 1969
- Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium GlutamateScience, 1969